Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed May 15, 2023
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-05-15$5.38/sh+10,000$53,770→ 1,015,766 total(indirect: See Footnote)
Holdings
- 4,907
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F2]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F3]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.